The elucidation of novel SH2 binding sites on PLD2

被引:35
作者
Di Fulvio, M.
Lehman, N.
Lin, X.
Lopez, I.
Gomez-Cambronero, J. [1 ]
机构
[1] Wright State Univ, Dept Physiol & Biophys, Sch Med, Dayton, OH 45435 USA
[2] Univ Illinois, Dept Pharmacol, Chicago, IL USA
关键词
PLD; Grb2; SOS; SH2; domains; cell signalling; cell proliferation; Ras/Erk pathway; site-directed mutagenesis;
D O I
10.1038/sj.onc.1209340
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our laboratory has recently reported that the enzyme phospholipase D2 (PLD2) exists as a ternary complex with PTP1b and the growth factor receptor bound protein 2 (Grb2). Here, we establish the mechanistic underpinnings of the PLD2/Grb2 association. We have identified residues Y-169 and Y-179 in the PLD2 protein as being essential for the Grb2 interaction. We present evidence indicating that Y-169 and Y179 are located within two consensus sites in PLD2 that mediate an SH2 interaction with Grb2. This was demonstrated with an SH2-deficient GSTGrb2 R86K mutant that failed to pull-down PLD2 in vitro. In order to elucidate the functions of the two neighboring tyrosines, we created a new class of deletion and point mutants in PLD2. Phenylalanine replacement of Y-169 (PLD2 Y169F)or Y-179 (PLD2 Y179F) reduced Grb2 binding while simultaneous mutation completely abolished it. The role of the two binding sites on PLD2 was found to be functionally nonequivalent: Y-169 serves to modulate the activity of the enzyme, whereas Y-179 regulates total tyrosine phosphorylation of the protein. Interestingly, binding of Grb2 to PLD2 occurs irrespectively of lipase activity, since Grb2 binds to catalytically inactive PLD2 mutants. Finally, PLD2 residues Y-169 and Y-179 are necessary for the recruitment of Sos, but only overexpression of the PLD2 Y179F mutant resulted in increased Ras activity, p44/42(Erk) phosphorylation and enhanced DNA synthesis. Since Y-169 remains able to modulate enzyme activity and is capable of binding to Grb2 in the PLD2 Y179F mutant, we propose that Y-169 is kept under negative regulation by Y-179. When this is released, Y-169 mediates cellular proliferation through the Ras/MAPK pathway.
引用
收藏
页码:3032 / 3040
页数:9
相关论文
共 35 条
[1]   Transmodulation between phospholipase D and c-Src enhances cell proliferation [J].
Ahn, BH ;
Kim, SY ;
Kim, EH ;
Choi, KS ;
Kwon, TK ;
Lee, YH ;
Chang, JS ;
Kim, MS ;
Jo, YH ;
Min, DS .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (09) :3103-3115
[2]   Implication of phospholipase D2 in oxidant-induced phosphoinositide 3-kinase signaling via Pyk2 activation in PC12 cells [J].
Banno, Y ;
Ohguchi, K ;
Matsumoto, N ;
Koda, M ;
Ueda, M ;
Hara, A ;
Dikic, I ;
Nozawa, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :16319-16324
[3]  
BOURGOIN S, 1992, J BIOL CHEM, V267, P11908
[4]   HUMAN SOS1 - A GUANINE-NUCLEOTIDE EXCHANGE FACTOR FOR RAS THAT BINDS TO GRB2 [J].
CHARDIN, P ;
CAMONIS, JH ;
GALE, NW ;
VANAELST, L ;
SCHLESSINGER, J ;
WIGLER, MH ;
BARSAGI, D .
SCIENCE, 1993, 260 (5112) :1338-1343
[5]   Activation of RBL-2H3 mast cells is dependent on tyrosine phosphorylation of phospholipase D2 by Fyn and Fgr [J].
Choi, WS ;
Hiragun, T ;
Lee, JH ;
Kim, YM ;
Kim, HP ;
Chahdi, A ;
Her, E ;
Han, JW ;
Beaven, MA .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (16) :6980-6992
[6]   Signalling roles of mammalian phospholipase D1 and D2 [J].
Cockcroft, S .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (11) :1674-1687
[7]   Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity [J].
Di Fulvio, M ;
Coleoni, AH ;
Pellizas, CG ;
Masini-Repiso, AM .
JOURNAL OF ENDOCRINOLOGY, 2000, 166 (01) :173-182
[8]   ASSOCIATION OF SOS RAS EXCHANGE PROTEIN WITH GRB2 IS IMPLICATED IN TYROSINE KINASE SIGNAL TRANSDUCTION AND TRANSFORMATION [J].
EGAN, SE ;
GIDDINGS, BW ;
BROOKS, MW ;
BUDAY, L ;
SIZELAND, AM ;
WEINBERG, RA .
NATURE, 1993, 363 (6424) :45-51
[9]   Phospholipase D [J].
Exton, JH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1998, 1436 (1-2) :105-115
[10]  
Foster DA, 2003, MOL CANCER RES, V1, P789